Medical Journal of the Islamic Republic Of Iran

en Prevalence of Persisting and New Symptoms Following Recovery from COVID-19 in the Jordanian Population COVID 19 Original Research Original Research Background: Many patients do not have a clear idea about the recovery from COVID-19 infection. This study focuses on the prevalence of persistent symptoms of COVID-19 infection as well as new symptoms that appear after recovery, and it aids in determining the relationships between these symptoms and a variety of variables.    Methods: An online observational study was conducted between April and June 2022. It consisted of a self-administered web-based questionnaire conducted using social media platforms. Inclusion criteria were residency in Jordan, being 18 years of age or older, having recovered from COVID-19 for at least 90 days, and giving consent to participate. Participants whose infection was not confirmed by a positive PCR were excluded.    Results: The most common persistent symptoms were loss of smell (34.7%), fatigue (34.6%), loss of taste (29.5%), myalgia (26.3%), and headache (25.9%), while the most common newly appearing symptoms after recovery were smell hallucinations (15.8%), fatigue (15.5%), taste hallucinations (14.9%), and focus impairment (12.9%) and smell impairment (12.8%). The symptoms persisted more in females, non-smokers, and those who needed medical care sor oxygesnation and with increased infection duration.    Conclusion: The study about persistent and new symptoms after COVID-19 among Jordanians found a greater prevalence of symptoms related to the sense of smell. There is no association between persistent and new symptoms after COVID-19 recovery with comorbidities or oxygen therapy during illness. We recommend studying the effect of COVID-19 mutants and vaccination on the persistence of symptoms after recovery. <quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal><quillbot-extension-portal></quillbot-extension-portal> COVID-19, Post-recovery, Persistent symptoms, New symptoms, Jordan 825 833 http://mjiri.iums.ac.ir/browse.php?a_code=A-10-8295-1&slc_lang=en&sid=1 Hatem M. Jaber hjaber@bau.edu.jo 200319475328460079798 200319475328460079798 Yes Department of Community Medicine, School of Medicine, Al-Balqa Applied University, As-Salt, Jordan Mohammad Abusamak mabusamak@bau.com 200319475328460079799 200319475328460079799 No Department of General and Special Surgery, Division of Ophthalmology, Faculty of Medicine, Al Balqa Applied University, Salt, Jordan Sajedah N.Obeid sajedahnizar98@gmail.com 200319475328460079800 200319475328460079800 No Faculty of Medicine, Al-Balqa Applied University, Jordan Nizar Heissat Nezar.yaya1997@gmail.com 200319475328460079801 200319475328460079801 No Anesthesia and intensive care Unit, Islamic Hospital, Amman, Jordan Razan Qashou' razanqashou98@gmail.com 200319475328460079802 200319475328460079802 No Faculty of Medicine, Al-Balqa Applied University, Jordan Mohammad AB Shtaiyat mohamedshtayat1997@gmail.com 200319475328460079803 200319475328460079803 No Faculty of Medicine, Al-Balqa Applied University, Jordan Ibrahim Alasad alasadibrahim41@gmail.com 200319475328460079804 200319475328460079804 No Faculty of Medicine, Al-Balqa Applied University, Jordan Dana Aldaghlise ddaghlise@gmail.com 200319475328460079805 200319475328460079805 No Family Medicine Specialist, Ministry of Health, Jordan